FTRE
Fortrea Holdings Inc.
NASDAQ: FTRE · HEALTHCARE · BIOTECHNOLOGY
$17.20
+1.06% today
Updated 2026-09-11
Market cap
$1.60B
P/E ratio
—
P/S ratio
0.60x
EPS (TTM)
$-0.83
Dividend yield
—
52W range
$8 – $21
Volume
1.3M
Fortrea Holdings Inc. (FTRE) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$17.20
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$8.21
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1B | $2.8B | $2.8B | $2.7B | $2.7B | $2.8B | $2.8B | $2.8B | $2.8B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 1.09% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -3.18%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.